Financials
Income statement
| Fiscal date | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 |
|---|---|---|---|---|
| Total reported revenue | 986.8M | 942.1M | 868.8M | 828.7M |
| Cost of revenue | 333.2M | 320.9M | 288.1M | 272.5M |
| Gross profit | 653.6M | 621.2M | 580.7M | 556.2M |
| Operating expense | ||||
| Research & development | 492.5M | 442.4M | 437.7M | 410.8M |
| Selling general and admin | 547.8M | 544.2M | 498.4M | 494.0M |
| Other operating expenses | — | — | — | — |
| Operating income | -386.7M | -365.5M | -355.3M | -348.6M |
| Non operating interest income | ||||
| Income | 56.3M | 48.7M | 49.3M | 54.8M |
| Expense | 2.1M | 689K | — | — |
| Other income expense | 2.4M | -8.5M | -7.9M | -21.3M |
| Pretax income | -330.1M | -326.0M | -314.0M | -315.1M |
| Tax provision | -4.3M | 1.9M | 3.8M | 2.7M |
| Net income | -325.7M | -327.9M | -317.8M | -317.8M |
| Basic EPS | — | 0.0 | 0.0 | 0.0 |
| Diluted EPS | — | 0.0 | 0.0 | 0.0 |
| Basic average shares | — | 13.3B | 13.4B | 13.3B |
| Diluted average shares | — | 13.3B | 13.4B | 13.3B |
| EBITDA | -282.2M | -269.6M | -303.7M | -287.7M |
| Net income from continuing op. | -325.7M | -327.9M | -317.8M | -317.8M |
| Minority interests | -1.8M | 3.6M | 871K | 828K |
| Preferred stock dividends | — | — | — | — |